Physician profile
Michael S Halbreiner
NPI 1972778876
$21,960.28
in general payments reported to CMS, 2019-2025
14 companies · $9,924 in 2025
The $9,924 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,779 · 2020: $18.53 · 2021: $336 · 2022: $1,076 · 2023: $974 · 2024: $4,853 · 2025: $9,924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,240 · Food and Beverage: $3,832 · Travel and Lodging: $2,679 · Honoraria: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,240.00 |
| Food and Beverage | $3,832.11 |
| Travel and Lodging | $2,679.02 |
| Honoraria | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $8,675.20 | 2025 | Amds-Ascyrus Medical |
| Edwards Lifesciences Corporation | $5,109.37 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Livanova USA, INC. | $3,979.79 | 2019-2021 | |
| Medtronic, INC. | $2,818.67 | 2021-2025 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $417.24 | 2019 | |
| Abbott Laboratories | $275.19 | 2019-2024 | Navitor |
| Atricure, INC. | $193.36 | 2023-2024 | |
| Abiomed | $128.78 | 2019-2025 | |
| Bolton Medical INC | $111.84 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Medistim USA, INC. | $106.12 | 2019 | |
| Ethicon US, LLC | $56.06 | 2022 | |
| Depuy Synthes Sales INC. | $42.80 | 2024 | Matrixrib |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $28.41 | 2025 | |
| Terumo Medical Corporation | $17.45 | 2023 | Tr Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Halbreiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.